The Patient Ratings and comments are gathered from our Patient Satisfaction Survey and displayed in their entirety.
Stay Connected. Manage Your Care.
Access your health information anytime and anywhere, at home or on the go, with MyHealth.
- Message your clinic
- View your lab results
- Schedule your next appointment
- Pay your bill
The MyHealth mobile app from Stanford Health Care puts all your health information at your fingertips and makes managing your health care simple and quick.
Guest Services
24/7
We are available to assist you
whenever you need it. Give us a call at
650-498-3333 or
PHYSICIAN HELPLINE
Have a question? We're here to help! Call 1-866-742-4811
Monday - Friday, 8 a.m. - 5 p.m.
REFER A PATIENT
Fax 650-320-9443
Track your patients' progress and communicate with Stanford providers conveniently and securely.
Sharon Sha, MD, MS
Memory disorders specialist
Clinical Assistant Professor, Neurology & Neurological Sciences
Bio:
Dr. Sha received her Bachelor’s degrees from UC Berkeley in Cognitive Science and Molecular Cell Biology, emphasizing in Neurobiology. She went on to obtain a Master’s degree in Physiology and MD from Georgetown University. She trained in Neurology at UCLA and Stanford University, and completed a clinical and research fellowship in Behavioral Neurology at UCSF, where she focused on identifying biomarkers for genetic forms of frontotemporal dementia and caring for patients with movement disorders and cognitive impairment.
While at UCSF, she saw the majority of patients with Huntington’s disease and ataxia in clinic and research, including ENROLL HD and the Natural History Study of and Genetic Modifiers in Spinocerebellar Ataxias. She has been a member of the Hungtington’s Study Group since 2011. She is board-certified in Neurology by the American Board of Psychiatry and Neurology and subspecialty boarded in Behavioral Neurology and Neuropsychiatry by the United Council for Neurologic Subspecialties.
Dr. Sha’s clinical expertise include Alzheimer’s disease, frontotemporal dementia, Lewy Body disease, corticobasal syndrome, progressive supranuclear palsy, Huntington’s disease, ataxia, multiple system atrophy, and other dementias.
Dr. Sha’s non-clinical time is spent conducting clinical trials in order to identify disease modifying treatments for dementia. She has a special interest in genetic forms of dementia and the cognitive impairment in Parkinsonian-related disorders.
While at UCSF, she saw the majority of patients with Huntington’s disease and ataxia in clinic and research, including ENROLL HD and the Natural History Study of and Genetic Modifiers in Spinocerebellar Ataxias. She has been a member of the Hungtington’s Study Group since 2011. She is board-certified in Neurology by the American Board of Psychiatry and Neurology and subspecialty boarded in Behavioral Neurology and Neuropsychiatry by the United Council for Neurologic Subspecialties.
Dr. Sha’s clinical expertise include Alzheimer’s disease, frontotemporal dementia, Lewy Body disease, corticobasal syndrome, progressive supranuclear palsy, Huntington’s disease, ataxia, multiple system atrophy, and other dementias.
Dr. Sha’s non-clinical time is spent conducting clinical trials in order to identify disease modifying treatments for dementia. She has a special interest in genetic forms of dementia and the cognitive impairment in Parkinsonian-related disorders.
- 300 Pasteur Drive
- 3rd Floor, Room A301
- Stanford, CA 94305
- Phone: 650-723-6469
- 300 Pasteur Drive
- 3rd Floor, Room A301
- Stanford, CA 94305
- Phone: 650-723-6469
Professional Education
- Board Certification: Behavioral Neurology and Neuropsychiatry, United Council for Neurologic Subspecialties (2014)
- Residency: Stanford University School of Medicine (2010) CA
- Medical Education: Georgetown University (2006) DC
- Fellowship: University of California San Francisco (2013) CA
- Board Certification: Neurology, American Board of Psychiatry and Neurology (2010)
- Residency: University of California Los Angeles (2008) CA
- Internship: California Pacific Medical Center (2007) CA
Administrative Appointments
- Director, Behavioral Neurology and Neuropsychiatry Fellowship (2015 - Present)
Publications
-
Predicting amyloid status in corticobasal syndrome using modified clinical criteria, magnetic resonance imaging and fluorodeoxyglucose positron emission tomography.
Sha, S. J., Ghosh, P. M., Lee, S. E., Corbetta-Rastelli, C., Jagust, W. J., & Rabinovici, G. D. (2015). Predicting amyloid status in corticobasal syndrome using modified clinical criteria, magnetic resonance imaging and fluorodeoxyglucose positron emission tomography. Alzheimer's research & therapy, 7(1), 8-?. -
Early-onset Alzheimer's disease versus frontotemporal dementia: resolution with genetic diagnoses?
Sha, S. J., Khazenzon, A. M., Ghosh, P. M., Rankin, K. P., Pribadi, M., & Lee, S. E. (2015). Early-onset Alzheimer's disease versus frontotemporal dementia: resolution with genetic diagnoses?. Neurocase, 1-7. -
Altered network connectivity in frontotemporal dementia with C9orf72 hexanucleotide repeat expansion
Lee, S. E., Khazenzon, A. M., Trujillo, A. J., Guo, C. C., Yokoyama, J. S., & Seeley, W. W. (2014). Altered network connectivity in frontotemporal dementia with C9orf72 hexanucleotide repeat expansion. BRAIN, 137, 3047-3060. -
Quantitative 7T Phase Imaging in Premanifest Huntington Disease
Apple, A. C., Possin, K. L., Satris, G., JOHNSON, E., Lupo, J. M., & Hess, C. P. (2014). Quantitative 7T Phase Imaging in Premanifest Huntington Disease. AMERICAN JOURNAL OF NEURORADIOLOGY, 35(9), 1707-1713.
-
Executive Functions in Premanifest Huntington's Disease
You, S. C., Geschwind, M. D., Sha, S. J., Apple, A., Satris, G., & Possin, K. L. (2014). Executive Functions in Premanifest Huntington's Disease. MOVEMENT DISORDERS, 29(3), 405-409.
-
Interrater reliability of the new criteria for behavioral variant frontotemporal dementia
LaMarre, A. K., Rascovsky, K., Bostrom, A., Toofanian, P., Wilkins, S., & Kramer, J. H. (2013). Interrater reliability of the new criteria for behavioral variant frontotemporal dementia. NEUROLOGY, 80(21), 1973-1977.
-
Frontotemporal dementia due to C9ORF72 mutations Clinical and imaging features
Sha, S. J., Takada, L. T., Rankin, K. P., Yokoyama, J. S., Rutherford, N. J., & Boxer, A. L. (2012). Frontotemporal dementia due to C9ORF72 mutations Clinical and imaging features. NEUROLOGY, 79(10), 1002-1011.
-
Atypical, slowly progressive behavioural variant frontotemporal dementia associated with C9ORF72 hexanucleotide expansion
Khan, B. K., Yokoyama, J. S., Takada, L. T., Sha, S. J., Rutherford, N. J., & Miller, B. L. (2012). Atypical, slowly progressive behavioural variant frontotemporal dementia associated with C9ORF72 hexanucleotide expansion. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 83(4), 358-364.
-
Neuropsychiatric features of C9orf72-associated behavioral variant frontotemporal dementia and frontotemporal dementia with motor neuron disease
Takada, L. T., & Sha, S. J. (2012). Neuropsychiatric features of C9orf72-associated behavioral variant frontotemporal dementia and frontotemporal dementia with motor neuron disease. ALZHEIMERS RESEARCH & THERAPY, 4(5).
-
Treatment implications of C9ORF72
Sha, S. J., & Boxer, A. (2012). Treatment implications of C9ORF72. ALZHEIMERS RESEARCH & THERAPY, 4(6).
-
Are frontotemporal lobar degeneration, progressive supranuclear palsy and corticobasal degeneration distinct diseases?
Sha, ron S., Hou, C., Viskontas, I. V., & Miller, B. L. (2006). Are frontotemporal lobar degeneration, progressive supranuclear palsy and corticobasal degeneration distinct diseases?. NATURE CLINICAL PRACTICE NEUROLOGY, 2(12), 658-665.
-
Distinctive neuropsychological patterns in frontotemporal dementia, semantic dementia, and Alzheimer disease.
Kramer, J. H., Jurik, J., Sha, S. J., Rankin, K. P., Rosen, H. J., & Miller, B. L. (2003). Distinctive neuropsychological patterns in frontotemporal dementia, semantic dementia, and Alzheimer disease. Cognitive and behavioral neurology , 16(4), 211-218.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
Patient Comments
Patients comments are gathered from our Patient Satisfaction Survey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
SHC Patient, Aug 2015
Professional.
SHC Patient, Aug 2015
Again, I wasn't getting the LP for an illness, but she & her team were great.
SHC Patient, Jul 2015
Both my husband and I thought highly of her.
SHC Patient, May 2015
Couldn't have asked for a better care system. Outstanding!
SHC Patient, May 2015
We love Dr Sha. We fly up from Southern CA every 6 months to see her. She is excellent at explaining where we are with my Wife's LPA.
SHC Patient, Apr 2015
I am quite familiar with the relevant medical jargon, and she was comfortable talking at a highly technical level back and forth with me, which I appreciate VERY much. She is MUCH better with this than many/most docs.
SHC Patient, Mar 2015
Dr. Sha is the model from which all doctors should aspire to be. Direct, honest, confident and kind.
SHC Patient, Feb 2015
Dr. Sha was outstanding.
SHC Patient, May 2014
Good experience.
SHC Patient, Apr 2014
Excellent service by Dr. Sha, she is friendly & knowledgeable. I have high confidence in her.
SHC Patient, Mar 2014
Dr. Sha is a true lady and I have complete confidence in her as a doctor.
SHC Patient, Jan 2014
The entire staff have made my experience. 'EXCELLENT.'
SHC Patient, Aug 2015
Professional.
SHC Patient, Aug 2015
Again, I wasn't getting the LP for an illness, but she & her team were great.
SHC Patient, Jul 2015
Both my husband and I thought highly of her.
SHC Patient, May 2015
Couldn't have asked for a better care system. Outstanding!
SHC Patient, May 2015
We love Dr Sha. We fly up from Southern CA every 6 months to see her. She is excellent at explaining where we are with my Wife's LPA.
SHC Patient, Apr 2015
I am quite familiar with the relevant medical jargon, and she was comfortable talking at a highly technical level back and forth with me, which I appreciate VERY much. She is MUCH better with this than many/most docs.
SHC Patient, Mar 2015
Dr. Sha is the model from which all doctors should aspire to be. Direct, honest, confident and kind.
SHC Patient, Feb 2015
Dr. Sha was outstanding.
SHC Patient, May 2014
Good experience.
SHC Patient, Apr 2014
Excellent service by Dr. Sha, she is friendly & knowledgeable. I have high confidence in her.
SHC Patient, Mar 2014
Dr. Sha is a true lady and I have complete confidence in her as a doctor.
SHC Patient, Jan 2014
The entire staff have made my experience. 'EXCELLENT.'